首页 | 本学科首页   官方微博 | 高级检索  
检索        


Outcomes following liver transplantation from HCV-seropositive donors to HCV-seronegative recipients
Authors:Bashar Aqel  Karn Wijarnpreecha  Surakit Pungpapong  C Burcin Taner  Kunam Reddy  Michael Leise  Lanyu Mi  Rolland C Dickson
Institution:1. Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Phoenix, Arizona, USA;2. Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Jacksonville, Florida, USA;3. Department of Transplant, Mayo Clinic College of Medicine, Jacksonville, Florida, USA;4. Department of Transplant Surgery, Mayo Clinic College of Medicine, Phoenix, Arizona, USA;5. Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA;6. Department of Biostatistics, Mayo Clinic College of Medicine, Scottsdale, Arizona, USA;1. Department of General and Oncological Surgery. Mauriziano Hospital, Turin, Italy;2. Hepatobiliary Surgery, IRCCS San Raffaele Hospital, Milan, Italy;3. Department of Hepatobiliary Surgery, G.B. Rossi Hospital, University of Verona, Verona, Italy;4. Unit of Hepato-Biliary Surgery, Foundation “Policlinico Universitario A. Gemelli”, Università Cattolica del Sacro Cuore, Rome, Italy;1. Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clínic, Institut d''Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN-Liver), Barcelona, Spain;2. Liver Unit, Hospital Clínic, Institut d''Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain;3. Division of Gastroenterology, Azienda Ospedaliero-Universitaria di Modena and University of Modena and Reggio Emilia, Modena, Italy;4. PhD Program in Clinical and Experimental Medicine, University of Modena and Reggio Emilia, Modena, Italy;5. University Hospital of Padua, Multivisceral Transplant Unit, Gastroenterology, Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN-Liver) Padua, Italy;6. Centre de Diagnostic per l’Imatge, Hospital Clínic, Barcelona, Spain;7. Centro de Investigación Biomédica Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain;1. Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium;2. Foundation for Liver Research, London, UK;3. Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK;4. Department of Pathology, Aretaieion Hospital, National and Kapodistrian University of Athens, Athens, Greece;5. Institute of Pathology, Medical University of Graz, Graz, Austria;6. CHRU de Lille, Service des maladies de l’appareil digestif, Université Lille 2 and Inserm U995, France;1. Service d’Hépatologie Hopital Rangueil et CHU Toulouse et Université Paul Sabatier, Toulouse3, France;2. Service d’Hépatologie Hôpital La Pitié Salpétrière APHP, Paris, France;3. Service d’hépatologie, Hôpital Avicenne, Hôpitaux Universitaires Paris-Seine-Saint-Denis, Assistance-Publique Hôpitaux de Paris, Bobigny, France;4. Unité de Formation et de Recherche Santé Médecine et Biologie Humaine, Université Paris 13, Paris, France;5. Centre de Recherche des Cordeliers, Inserm, Sorbonne Université, Université Paris, INSERM UMR 1138, Functional Genomics of Solid Tumors laboratory, F-75006, Paris, France
Abstract:
><ol class=
  • Download : Download high-res image (163KB)
  • Download : Download full-size image
  • Keywords:Hepatitis C  Liver transplantation  Donation after cardiac death  DCD  Direct-acting antiviral  DAA  Glecaprevir/pibrentasvir
    本文献已被 ScienceDirect 等数据库收录!
    设为首页 | 免责声明 | 关于勤云 | 加入收藏

    Copyright©北京勤云科技发展有限公司  京ICP备09084417号